TearLab Announces a New Partnership in BENELUX

TearLab® Corp and NewLeaf Ophthalmology BV are pleased to inform you that we have entered into an Exclusive Distributor Agreement for sales and customer service of TearLab osmolarity systems and test cards in the BENELUX countries effective January 1st 2020.

NewLeaf is convinced biomarkers will play an increasing role in healthcare. Osmolarity today is not only an effective biomarker for diagnosing and treatment of dry eye disease, but also important in relation to refractive surgery, such as Lasik, PRK, PIOL´s and PRELEX, to manage patients expectations and patients recovery period. Tearlab is therefore putting a lot of effort in developing tomorrow's biomarkers. We will keep you updated.

Visit Tearlab´s website for more information: www.tearlab.com